Medical Oncology

Vascular Neurology

Questions discussed in this category

Do you typically use NOACs or Lovenox in patients with stroke due to hypercoagulability from malignancy?

Is there a role to continue aspirin in patients with myeloproliferative disorders who have never had a thrombotic event that are starting DOAC for stroke prophylaxis with newly diagnosed atrial fibrillation?

2 Answers available

How would you approach protein S deficiency found on hypercoagulability work-up in a patient with a post-operative central retinal vein occlusion?

In the setting of no personal or family history and no other risk factors for thrombosis, is systemic anticoagulation warranted if local treatments (e...

4 Answers available

Is antiplatelet or anticoagulant therapy preferred for the secondary prophylaxis of cryptogenic stroke in a patient with underlying malignancy?

4 Answers available

Papers discussed in this category

J Am Heart Assoc, 2020 Nov 23

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.

Am J Hematol,

Protein S abnormalities: a diagnostic nightmare.

The New England journal of medicine, 2018-02-15

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.

N Engl J Med, 2020 Mar 29

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.

N Engl J Med, 2003 Jul 10

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Medical Oncology

Vascular Neurology

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology